-+ 0.00%
-+ 0.00%
-+ 0.00%

Oppenheimer Reiterates Outperform on Xylem, Lowers Price Target to $150

Benzinga·10/14/2026 17:19:51
Listen to the news
Oppenheimer analyst Bryan Blair reiterates Xylem (NYSE:XYL) with a Outperform and lowers the price target from $158 to $150.